Healthcare provider profile · identity verified

John M Bruza, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1093758310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	407	129
Atorvastatin Calcium	Atorvastatin Calcium	377	125
Amlodipine Besylate	Amlodipine Besylate	318	105
Levothyroxine Sodium	Levothyroxine Sodium	242	80
Omeprazole	Omeprazole	207	64
Losartan Potassium	Losartan Potassium	167	47
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	159	44
Metoprolol Succinate	Metoprolol Succinate	159	48
Trazodone Hcl	Trazodone Hcl	140	47
Lisinopril	Lisinopril	139	45
Olmesartan Medoxomil	Olmesartan Medoxomil	122	47
Escitalopram Oxalate	Escitalopram Oxalate	114	34
Tamsulosin Hcl	Tamsulosin Hcl	97	31
Simvastatin	Simvastatin	91	29
Clonazepam	Clonazepam	90	15
Metformin Hcl	Metformin Hcl	90	27
Allopurinol	Allopurinol	88	21
Chlorthalidone	Chlorthalidone	86	26
Gabapentin	Gabapentin	86	36
Furosemide	Furosemide	83	25
Sertraline Hcl	Sertraline Hcl	81	24
Eliquis	Apixaban	80	22
Metformin Hcl Er	Metformin Hcl	77	23
Ozempic	Semaglutide	76	14
Alendronate Sodium	Alendronate Sodium	73	27
Hydrochlorothiazide	Hydrochlorothiazide	66	28
Famotidine	Famotidine	60	23
Lorazepam	Lorazepam	60	28
Mounjaro	Tirzepatide	58	suppressed
Donepezil Hcl	Donepezil Hcl	57	21
Zolpidem Tartrate	Zolpidem Tartrate	56	13
Ezetimibe	Ezetimibe	55	19
Myrbetriq	Mirabegron	54	17
Pantoprazole Sodium	Pantoprazole Sodium	54	14
Montelukast Sodium	Montelukast Sodium	53	15
Fluticasone Propionate	Fluticasone Propionate	52	23
Synthroid	Levothyroxine Sodium	51	14
Ipratropium Bromide	Ipratropium Bromide	49	27
Spironolactone	Spironolactone	49	16
Carvedilol	Carvedilol	48	14
Albuterol Sulfate Hfa	Albuterol Sulfate	46	22
Tramadol Hcl	Tramadol Hcl	45	15
Clopidogrel	Clopidogrel Bisulfate	44	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	14
Azelastine Hcl	Azelastine Hcl	41	18
Duloxetine Hcl	Duloxetine Hcl	40	16
Januvia	Sitagliptin Phosphate	40	suppressed
Atenolol	Atenolol	39	13
Potassium Chloride	Potassium Chloride	36	14
Memantine Hcl	Memantine Hcl	35	11
Bupropion Xl	Bupropion Hcl	34	suppressed
Mirtazapine	Mirtazapine	34	14
Pravastatin Sodium	Pravastatin Sodium	34	12
Pregabalin	Pregabalin	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	13
Buspirone Hcl	Buspirone Hcl	32	suppressed
Nifedipine Er	Nifedipine	32	12
Finasteride	Finasteride	31	suppressed
Ketoconazole	Ketoconazole	31	suppressed
Glipizide Er	Glipizide	29	suppressed
Alprazolam	Alprazolam	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Colchicine	Colchicine	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Repatha Sureclick	Evolocumab	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Donepezil Hcl Odt	Donepezil Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Valsartan	Valsartan	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Prednisone	Prednisone	16	11
Propranolol Hcl	Propranolol Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Estradiol	Estradiol	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Testosterone	Testosterone	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error